NDC 83337-232 - Acido Acetilsalicilico With enteric coat
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83337-232
- Package NDCs from labels
- 83337-232-24
- Manufacturer
- 4Medical Group LLC
- Effective date
- 2023-07-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Acido Acetilsalicilico With enteric coat - 4Medical Group LLC | 4Medical Group LLC | 2023-07-06 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 83337-232-24 | 2025-01-30 | C162847 | 48780-1 | 1030e365-5c3f-111a-e063-dadaa90a10e2 | OTC Label - Aspirin - Allegiant Health |
| 83337-232-24 | 2024-01-30 | C162847 | 48780-1 | 1030e365-5c3f-111a-e063-dadaa90a10e2 | OTC Label - Aspirin - Allegiant Health |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83337-232-24 | Acido AcetilsalicilicoWith enteric coat | 40 in 1 BOX | TABLET, COATED | 40 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Exel Clarifying Line SPF 50 | OCTINOXATE, OCTOCRYLENE, OXYBENZONE, TATANIUM DIOXIDE | Biocosmetica Exel Argentina SRL | e65a68f6-d1b7-4cbf-a3f8-5cc04036221a | 2024-06-23 | Warnings | 15FIX9V2JP |
| Butalbital, Aspirin, and Caffeine | BUTALBITAL, ASPIRIN, AND CAFFEINE | LGM PHARMA SOLUTIONS, LLC | a1c7b964-af71-4427-8f13-73b5e69ca525 | 2024-06-21 | Warnings, Adverse reactions | R16CO5Y76E |
| Codeine-Guaifenesin | CODEINE PHOSPHATE AND GUAIFENESIN | NuCare Pharmaceuticals,Inc. | 9e691264-d48a-6b48-e053-2995a90a9352 | 2024-06-20 | Warnings | M013 |
| Aspirin | REGULAR STRENGTH ENTERIC COATED ASPIRIN | NuCare Pharmceuticals,Inc. | a0705f4f-55cb-214a-e053-2995a90aa680 | 2024-06-20 | Warnings | M013 R16CO5Y76E |
| Extra Strength Pain Reliever | ACETAMINOPHEN 500 MG | Lil' Drug Store Products, Inc. | ee8e0e79-4da4-101f-e053-2a95a90a30a4 | 2024-06-19 | Warnings | M013 |
| Extra Strength Headache Relief | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Lil' Drug Store Products, Inc. | b3a06e4b-0b31-4e2a-8dd1-9de85760477b | 2024-06-19 | Warnings | M013 R16CO5Y76E |
| THERA Moisturizing Body Shield | DIMETHICONE | McKesson Medical-Surgical Inc. | 56869b64-11ee-4df6-8102-ce5818e0116e | 2024-06-18 | Warnings | 92RU3N3Y1O |
| Dimethicone | SKIN PROTECTANT | McKesson | 96886b33-44d4-5a2a-e053-2a95a90a505e | 2024-06-18 | Warnings | 92RU3N3Y1O |
| Protectif Fair Tint | ZINC OXIDE AND TITANIUM DIOXIDE | Derma Research Group Inc. | 1a8c8804-1d6b-b5a5-e063-6394a90a1260 | 2024-06-18 | Warnings | 15FIX9V2JP |
| pain relief | ACETAMINOPHEN | Meijer Distribution Inc | 43c3fe72-a4ef-48a6-bc22-a644919c0c5c | 2024-06-17 | Warnings | M013 |
| Aspirin Regular Strength | ASPIRIN | RETAIL BUSINESS SERVICES , LLC. | 093182a6-3ed8-5a3f-e063-6294a90a354a | 2024-06-14 | Warnings | M013 R16CO5Y76E |
| ACETAMINOPHEN PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | RETAIL BUSINESS SERVICES , LLC. | 093199be-e92a-6f60-e063-6294a90a8533 | 2024-06-14 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | RETAIL BUSINESS SERVICES , LLC. | 09315a3d-bb2d-4f06-e063-6294a90a3bd3 | 2024-06-14 | Warnings | M013 |
| Dimethicone | BODY CLEANSER | McKesson | 8ffe6ec3-8f5f-0c9b-e053-2995a90ac3a8 | 2024-06-14 | Warnings | 92RU3N3Y1O |
| Pain Relief Regular Strength | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION INC | 613bc633-0426-41a7-aea9-9ff56311b607 | 2024-06-13 | Warnings | M013 |
| Pain Relief Extra Strength | ACETAMINOPHEN | Chain Drug Marketing Association | cfaf9495-e654-4dfc-ba23-d2358c3720c4 | 2024-06-13 | Warnings | M013 |
| Migraine Relief | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | CHAIN DRUG MARKETING ASSOCIATION, INC. | a6a07615-3108-436f-bbce-be7cb89ce456 | 2024-06-13 | Warnings | R16CO5Y76E |
| Aspirin 81 mg Low Dose | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION, INC. | 18ff2df8-ee65-4219-ad93-cf5090bfac2d | 2024-06-13 | Warnings | M013 308416 R16CO5Y76E |
| Pain Relief Extra Strength | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION, INC. | 9fdbaf5e-f88b-4d18-97df-0b2e8dddf377 | 2024-06-13 | Warnings | M013 |
| Aspirin 81 mg Low dose | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION, INC. | bfb9af64-3195-44bf-bcf3-6b36b40d3cc7 | 2024-06-13 | Warnings | M013 308416 R16CO5Y76E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.